Screener
Mirum Pharmaceuticals, Inc. MIRM Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts payable, accrued expenses and other liabilities | 38,183 | 22,314 |
| Holdback liabilities | 71,529 | — |
| Operating lease liabilities | (1,213) | (803) |
| Net cash (used in) provided by operating activities | (273,015) | 10,079 |
| Investing activities | ||
| Purchase of investments | (195,612) | (65,063) |
| Proceeds from maturities of investments | 59,739 | 42,497 |
| Purchase of property and equipment | (687) | (167) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s operating cash flow?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating cash flow of -$44.25M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating cash flow decreased by 467.5% year-over-year, from $12.04M to -$44.25M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s operating cash flow?
- Over 3 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s operating cash flow has grown at a -25.1% compound annual growth rate (CAGR), from -$132.76M to $55.83M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude